Krishna Polu, based in California, United States, is currently a President and CEO at R1 Therapeutics. Krishna Polu brings experience from previous roles at Abingworth, Catalys Pacific, Lupus Ventures and Lupus Research Alliance. Krishna Polu holds a 2003 - 2005 Fellowship in Nephrology @ Harvard Medical School. With a robust skill set that includes Biopharmaceuticals, Biotechnology, CRO, Cancer, Cardiovascular Medicine and more. Krishna Polu has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Krishna Polu?
Find contact details for 700 million professionals.